Abstract
In this study, we have examined the role of glutamine derivatives in reducing 5-fluorouracil (5-FU)-induced epithelial damage in an undifferentiated crypt intestinal cell line, IEC-6. In this model, we have investigated proliferation indirectly by detecting the enzyme-derived formazan dye from the tetrazolium salt WST-1 in viable cells at 24 and 48 h after 5-FU treatment. Migration was measured at 12 and 24 h after razor scraping of the cell monolayer. Cell death was measured by quantifying the percentage of apoptotic and necrotic figures by flow cytometry at 12 and 24 h following 5-FU challenge. Neither glutamine nor alanyl-glutamine prevented 5-FU-induced apoptosis and necrosis in IEC-6 cells at 12 and 24 h after 5-FU challenge. However, glutamine and alanyl-glutamine enhanced migration and proliferation when compared with 5-FU-treated controls (P < 0.05). These new findings support our earlier study on the benefit of oral glutamine in enhancing epithelial recovery after 5-FU challenge.
Similar content being viewed by others
References
Potten CS (1975) Kinetics and possible regulation of crypt cell populations under normal and stress conditions. Bull Cancer 62:419–430
Potten CS (1986) Cell cycles in cell hierarchies. Int J Radiat Biol Relat Stud Phys Chem Med 49:257–278
Potten CS, Booth C (1997) The role of radiation-induced and spontaneous apoptosis in the homeostasis of the gastrointestinal epithelium: a brief review. Comp Biochem Physiol B Biochem Mol Biol 118:473–478
Clatworthy JP, Subramanian V (2001) Stem cells and the regulation of proliferation, differentiation and patterning in the intestinal epithelium: emerging insights from gene expression patterns, transgenic and gene ablation studies. Mech Dev 101:3–9
Roncucci L, Pedroni M, Vaccina F, Benatti P, Marzona L, De PA (2000) Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics. Cell Prolif 33:1–18
Becciolini A, Balzi M, Fabbrica D, Potten CS (1996) Cell kinetics in rat small intestine after exposure to 3 Gy of gamma-rays at different times of the day. Int J Radiat Biol 70:281–288
Naughton PJ, Grant G, Ewen SW, Spencer RJ, Brown DS, Pusztai A, Bardocz S (1995) Salmonella typhimurium and Salmonella enteritidis induce gut growth and increase the polyamine content of the rat small intestine in vivo. FEMS Immunol Med Microbiol 12:251–258
Kelder W, Hospers GA, Plukker JT (2006) Effects of 5-fluorouracil adjuvant treatment of colon cancer. Expert Rev Anticancer Ther 6:785–794
Beretta GD, Milesi L, Pessi MA, Mosconi S, Labianca R (2004) Adjuvant treatment of colorectal cancer. Surg Oncol 13:63–73
Daniele B, Secondulfo M, De VR, Pignata S, De ML, Delrio P, Palaia R, Barletta E, Tambaro R, Carratu R (2001) Effect of chemotherapy with 5-fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer. J Clin Gastroenterol 32:228–230
Duncan M , Grant G (2003) Oral and intestinal mucositis—causes and possible treatments. Aliment Pharmacol Ther 18:853–874
Cynober LA (2002) Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition 18:761–766
Oehler R, Roth E (2003) Regulative capacity of glutamine. Curr Opin Clin Nutr Metab Care 6:277–282
Neu J, DeMarco V, Li N (2002) Glutamine: clinical applications and mechanisms of action. Curr Opin Clin Nutr Metab Care 5:69–75
O’Connell MJ (2004) Current status of adjuvant therapy for colorectal cancer. Oncology (Williston Park) 18:751–755
Elia M, Lunn PG (1997) The use of glutamine in the treatment of gastrointestinal disorders in man. Nutrition 13:743–747
Carneiro-Filho BA, Lima IP, Araujo DH, Cavalcante MC, Carvalho GH, Brito GA, Lima V, Monteiro SM, Santos FN, Ribeiro RA, Lima AA (2004) Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis. Dig Dis Sci 49:65–72
Daniele B, Perrone F, Gallo C, Pignata S, De MS, De VR, Barletta E, Tambaro R, Abbiati R, D’Agostino L (2001) Oral glutamine in the prevention of fluorouracil induced intestinal toxicity a double blind, placebo controlled, randomised trial. Gut 48:28–33
Yalcin SS, Yurdakok K, Tezcan I, Oner L (2004) Effect of glutamine supplementation on diarrhea, interleukin-8 and secretory immunoglobulin A in children with acute diarrhea. J Pediatr Gastroenterol Nutr 38:494–501
Lima AA, Guerrant RL (2005) Glutamine for childhood malnutrition: is it needed? J Pediatr Gastroenterol Nutr 40:526–527
Carneiro-Filho BA, Bushen OY, Brito GA, Lima AA, Guerrant RL (2003) Glutamine analogues as adjunctive therapy for infectious diarrhea. Curr Infect Dis Rep 5:114–119
Kelly D, Wischmeyer PE (2003) Role of L-glutamine in critical illness: new insights. Curr Opin Clin Nutr Metab Care 6:217–222
Furst P (2001) New developments in glutamine delivery. J Nutr 131:2562S–2568S
Buchman AL (1999) Glutamine for the gut: mystical properties or an ordinary amino acid? Curr Gastroenterol Rep 1:417–423
Carneiro-Filho BA, Oria RB, Wood RK, Brito GA, Fujii J, Obrig T, Lima AA, Guerrant RL (2004) Alanyl-glutamine hastens morphologic recovery from 5-fluorouracil-induced mucositis in mice. Nutrition 20:934–941
Miller AL (1999) Therapeutic considerations of L-glutamine: a review of the literature. Altern Med Rev 4:239–248
Hirata K, Horie T (2003) Stimulation of intestinal epithelial restitution by prostaglandin E(1) analogue. Cancer Chemother Pharmacol 51:216–220
McCormack SA, Viar MJ, Johnson LR (1992) Migration of IEC-6 cells: a model for mucosal healing. Am J Physiol 263:G426–G435
Daniele B, Secondulfo M, De VR, Pignata S, De ML, Delrio P, Palaia R, Barletta E, Tambaro R, Carratu R (2001) Effect of chemotherapy with 5-fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer. J Clin Gastroenterol 32:228–230
Fata F, Ron IG, Kemeny N, O’Reilly E, Klimstra D, Kelsen DP (1999) 5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma. Cancer 86:1129–1134
Potten CS (1998) Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos Trans R Soc Lond B Biol Sci 353:821–830
Gu Y, Wu ZH (2002) The anabolic effects of recombinant human growth hormone and glutamine on parenterally fed, short bowel rats. World J Gastroenterol 8:752–757
Ziegler TR, Mantell MP, Chow JC, Rombeau JL, Smith RJ (1996) Gut adaptation and the insulin-like growth factor system: regulation by glutamine and IGF-I administration. Am J Physiol 271:G866–G875
Alexander AN, Carey HV (2002) Insulin-like growth factor-I stimulates Na+-dependent glutamine absorption in piglet enterocytes. Dig Dis Sci 47:1129–1134
Ray EC, Avissar NE, Sax HC (2002) Growth factor regulation of enterocyte nutrient transport during intestinal adaptation. Am J Surg 183:361–371
Mithieux G (2001) New data and concepts on glutamine and glucose metabolism in the gut. Curr Opin Clin Nutr Metab Care 4:267–271
Kudsk KA (2002) Current aspects of mucosal immunology and its influence by nutrition. Am J Surg 183:390–398
Keefe DM, Brealey J, Goland GJ, Cummins AG (2000) Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 47:632–637
Papaconstantinou HT, Chung DH, Zhang W, Ansari NH, Hellmich MR, Townsend CM Jr, Ko TC (2000) Prevention of mucosal atrophy: role of glutamine and caspases in apoptosis in intestinal epithelial cells. J Gastrointest Surg 4:416–423
Fuchs BC, Bode BP (2005) Stressing out over survival: glutamine as an apoptotic modulator. J Surg Res 131:26–40
Curi R, Lagranha CJ, Doi SQ, Sellitti DF, Procopio J, Pithon-Curi TC, Corless M, Newsholme P (2005) Molecular mechanisms of glutamine action. J Cell Physiol 204:392–401
Papaconstantinou HT, Chung DH, Zhang W, Ansari NH, Hellmich MR, Townsend CM Jr, Ko TC (2000) Prevention of mucosal atrophy: role of glutamine and caspases in apoptosis in intestinal epithelial cells. J Gastrointest Surg 4:416–423
Paquette JC, Guerin PJ, Gauthier ER (2005) Rapid induction of the intrinsic apoptotic pathway by L-glutamine starvation. J Cell Physiol 202:912–921
Mates JM, Segura JA, Alonso FJ, Marquez J (2006) Pathways from glutamine to apoptosis. Front Biosci 11:3164–3180
Kircher B, Eibl G, Enrich B, Latzer K, Herold M, Niederwieser D (2002) The role of L-alanyl-L-glutamine in the immune response in vitro. Wien Klin Wochenschr 114:702–708
Brito GA, Carneiro-Filho B, Oria RB, Destura RV, Lima AA, Guerrant RL (2005) Clostridium difficile toxin A induces intestinal epithelial cell apoptosis and damage: role of Gln and Ala-Gln in toxin A effects. Dig Dis Sci 50:1271–1278
Carneiro BA, Fujii J, Brito GA, Alcantara C, Oria RB, Lima AA, Obrig T, Guerrant RL (2006) Caspase and bid involvement in Clostridium difficile toxin A-induced apoptosis and modulation of toxin A effects by glutamine and alanyl-glutamine in vivo and in vitro. Infect Immun 74:81–87
Papaconstantinou HT, Chung DH, Zhang W, Ansari NH, Hellmich MR, Townsend CM Jr, Ko TC (2000) Prevention of mucosal atrophy: role of glutamine and caspases in apoptosis in intestinal epithelial cells. J Gastrointest Surg 4:416–423
Evans ME, Jones DP, Ziegler TR (2003) Glutamine prevents cytokine-induced apoptosis in human colonic epithelial cells. J Nutr 133:3065–3071
Decker GM (2002) Glutamine: indicated in cancer care? Clin J Oncol Nurs 6:112–115
Brito GA, Carneiro-Filho B, Oria RB, Destura RV, Lima AA, Guerrant RL (2005) Clostridium difficile toxin A induces intestinal epithelial cell apoptosis and damage: role of Gln and Ala-Gln in toxin A effects. Dig Dis Sci 50:1271–1278
Kim KA, Kakitani M, Zhao J, Oshima T, Tang T, Binnerts M, Liu Y, Boyle B, Park E, Emtage P, Funk WD, Tomizuka K (2005) Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science 309:1256–1259
Acknowledgment
This study was supported by the following grants from the National Institutes of Health: ABC Grant no. 5 D43 TW001136, and GIDRT Grant no. 5 D43 TW006578.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Braga-Neto, M.B., Warren, C.A., Oriá, R.B. et al. Alanyl-Glutamine and Glutamine Supplementation Improves 5-Fluorouracil-Induced Intestinal Epithelium Damage In Vitro. Dig Dis Sci 53, 2687–2696 (2008). https://doi.org/10.1007/s10620-008-0215-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-008-0215-0